BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Davis M. Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics. Clin Pharmacokinet 2007;46:825-50. [PMID: 17854233 DOI: 10.2165/00003088-200746100-00002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Dwyer JP, Jayasekera C, Nicoll A. Analgesia for the cirrhotic patient: a literature review and recommendations. J Gastroenterol Hepatol. 2014;29:1356-1360. [PMID: 24548074 DOI: 10.1111/jgh.12560] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
2 Gao J, Xu G, Xu P. Comparative transcriptome analysis reveals metabolism transformation in Coilia nasus larvae during the mouth-open period. Comparative Biochemistry and Physiology Part D: Genomics and Proteomics 2020;36:100712. [DOI: 10.1016/j.cbd.2020.100712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Smith H, Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs Aging 2010;27:417-33. [PMID: 20450239 DOI: 10.2165/11536540-000000000-00000] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
4 Mccain JD, Chascsa DM, Lindor KD. Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients. Expert Opinion on Orphan Drugs 2021;9:53-66. [DOI: 10.1080/21678707.2021.1898370] [Reference Citation Analysis]
5 Mcpherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J, Malotte K, Lockman DK, Wellman C, Salpeter S, Bemben NM, Ray JB, Lapointe BJ, Chou R. Safe and Appropriate Use of Methadone in Hospice and Palliative Care: Expert Consensus White Paper. Journal of Pain and Symptom Management 2019;57:635-645.e4. [DOI: 10.1016/j.jpainsymman.2018.12.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 6.3] [Reference Citation Analysis]
6 Martinez M, Modric S. Patient variation in veterinary medicine: part I. Influence of altered physiological states: Variability in drug response. Journal of Veterinary Pharmacology and Therapeutics 2010;33:213-26. [DOI: 10.1111/j.1365-2885.2009.01139.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
7 Bosilkovska M, Walder B, Besson M, Daali Y, Desmeules J. Analgesics in patients with hepatic impairment: pharmacology and clinical implications. Drugs. 2012;72:1645-1669. [PMID: 22867045 DOI: 10.2165/11635500-000000000-00000] [Cited by in Crossref: 95] [Cited by in F6Publishing: 62] [Article Influence: 9.5] [Reference Citation Analysis]
8 Bodnar RJ. Endogenous opiates and behavior: 2007. Peptides 2008;29:2292-375. [DOI: 10.1016/j.peptides.2008.09.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
9 Edmonds KP, Saunders IM, Willeford A, Ajayi TA, Atayee RS. Emerging Challenges to the Safe and Effective Use of Methadone for Cancer-Related Pain in Paediatric and Adult Patient Populations. Drugs 2020;80:115-30. [PMID: 31820362 DOI: 10.1007/s40265-019-01234-6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Oliverio C, Malone N, Rosielle DA. Opoid use in liver failure #260. J Palliat Med 2012;15:1389-91. [PMID: 23206153 DOI: 10.1089/jpm.2012.9543] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008;64:1147-1161. [PMID: 18762933 DOI: 10.1007/s00282-008-0553-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008;64:1147-1161. [PMID: 18762933 DOI: 10.1007/s00228-008-0553-z] [Cited by in Crossref: 375] [Cited by in F6Publishing: 301] [Article Influence: 26.8] [Reference Citation Analysis]
13 Davis MP. Twelve Reasons for Considering Buprenorphine as a Frontline Analgesic in the Management of Pain. The Journal of Supportive Oncology 2012;10:209-19. [DOI: 10.1016/j.suponc.2012.05.002] [Cited by in Crossref: 105] [Cited by in F6Publishing: 90] [Article Influence: 10.5] [Reference Citation Analysis]
14 Geusens B, Mollet I, Anderson CD, Terras S, Roberts MS, Lambert J. Changes in Skin Immunity with Age and Disease. In: Dayan N, Wertz PW, editors. Innate Immune System of Skin and Oral Mucosa. Hoboken: John Wiley & Sons, Inc.; 2011. pp. 215-58. [DOI: 10.1002/9781118025338.ch11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Badhan RK, Gittins R, Al Zabit D. The optimization of methadone dosing whilst treating with rifampicin: A pharmacokinetic modeling study. Drug and Alcohol Dependence 2019;200:168-80. [DOI: 10.1016/j.drugalcdep.2019.03.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Jin Y, Lu L, Tu W, Luo T, Fu Z. Impacts of polystyrene microplastic on the gut barrier, microbiota and metabolism of mice. Sci Total Environ 2019;649:308-17. [PMID: 30176444 DOI: 10.1016/j.scitotenv.2018.08.353] [Cited by in Crossref: 172] [Cited by in F6Publishing: 159] [Article Influence: 43.0] [Reference Citation Analysis]
17 Chalabianloo F, Høiseth G, Vold JH, Johansson KA, Kringen MK, Dalgard O, Ohldieck C, Druckrey-Fiskaaen KT, Aas C, Løberg EM, Bramness JG, Fadnes LT. Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations. J Addict Dis 2022;:1-11. [PMID: 35356868 DOI: 10.1080/10550887.2022.2057140] [Reference Citation Analysis]
18 Han X, Jiang Y, Feng N, Yang P, Zhang M, Jin W, Zhang T, Huang Z, Zhao H, Zhang K, Liu S, Hu D. Comparison of the Homology Between Muskrat Scented Gland and Mouse Preputial Gland. J Mammal Evol. [DOI: 10.1007/s10914-022-09604-w] [Reference Citation Analysis]
19 Düll MM, Wolf K, Vetter M, Dietrich P, Neurath MF, Kremer AE. Endogenous Opioid Levels Do Not Correlate With Itch Intensity and Therapeutic Interventions in Hepatic Pruritus. Front Med (Lausanne) 2021;8:641163. [PMID: 33937284 DOI: 10.3389/fmed.2021.641163] [Reference Citation Analysis]
20 Barnett V, Twycross R, Mihalyo M, Wilcock A. Opioid Antagonists. Journal of Pain and Symptom Management 2014;47:341-52. [DOI: 10.1016/j.jpainsymman.2013.12.223] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
21 Nada EM, Alabdulkareem A. Morphine versus fentanyl patient-controlled analgesia for postoperative pain control in major hepatic resection surgeries including living liver donors: A retrospective study. Saudi J Anaesth 2018;12:250-5. [PMID: 29628836 DOI: 10.4103/sja.SJA_625_17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ahmadi S, Karami Z, Mohammadian A, Khosrobakhsh F, Rostamzadeh J. Cholestasis induced antinociception and decreased gene expression of MOR1 in rat brain. Neuroscience 2015;284:78-86. [DOI: 10.1016/j.neuroscience.2014.08.063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
23 Ostroumova OD, Pereverzev AP. Hepatic impairment as a risk factor of adverse drug reactions. Consilium Medicum 2021;23:939-48. [DOI: 10.26442/20751753.2021.12.201234] [Reference Citation Analysis]
24 Ojeda A, Moreno LA. Pain management in patients with liver cirrhosis. Gastroenterol Hepatol. 2014;37:35-45. [PMID: 24309482 DOI: 10.1016/j.gastrohep.2013.05.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]